Literature DB >> 15449170

Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium.

Tae-Sun Ha1, Chang-Ju Song, Joon-Ho Lee.   

Abstract

Perlecan is one of major heparan sulfate proteoglycans in the glomerular basement membrane and is reduced in the renal parenchyma of diabetic patients and animals with proteinuria. To examine the effects of glucose and advanced glycosylated end-products (AGE) on perlecan, we cultured rat glomerular epithelial cells (GEpC) on AGE- or bovine serum albumin (BSA)-coated plates under normal (NG, 5 mM) and high-glucose (HG, 30 mM) conditions and measured the change in perlecan core protein production by a sandwich ELISA and northern blot analysis. We observed significant decreases of perlecan core protein under HG conditions at 1 week incubation, specifically on the AGE-coated compared with the BSA-coated surface, by 22.2% and 4.7%, respectively. The expression of mRNA for perlecan promoter was decreased under HG conditions on AGE-coated surfaces by 19.7% at 2 days and 61.1% at 1 week. Even under NG condition, the expression of mRNA was reduced by 30% at 1 week if GEpC were grown on an AGE-coated surface. In conclusion, HG and AGE have an additive effect in reducing the production of perlecan core protein by GEpC in vitro. AGE had a greater effect than HG, implying that the inhibition of AGE formation may be more effective than short-term glucose control in the prevention of diabetic proteinuria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15449170     DOI: 10.1007/s00467-004-1590-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  29 in total

1.  Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II.

Authors:  N F van Det; N A Verhagen; J T Tamsma; J H Berden; J A Bruijn; M R Daha; F J van der Woude
Journal:  Diabetes       Date:  1997-05       Impact factor: 9.461

Review 2.  Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria.

Authors:  C J Raats; J Van Den Born; J H Berden
Journal:  Kidney Int       Date:  2000-02       Impact factor: 10.612

3.  Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium.

Authors:  B S Kasinath; P Grellier; G G Choudhury; S L Abboud
Journal:  J Cell Physiol       Date:  1996-04       Impact factor: 6.384

4.  Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells.

Authors:  N F van Det; J van den Born; J T Tamsma; N A Verhagen; J H Berden; J A Bruijn; M R Daha; F J van der Woude
Journal:  Kidney Int       Date:  1996-04       Impact factor: 10.612

Review 5.  The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices.

Authors:  R V Iozzo; I R Cohen; S Grässel; A D Murdoch
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

Review 6.  The extracellular matrix in diabetic nephropathy.

Authors:  F N Ziyadeh
Journal:  Am J Kidney Dis       Date:  1993-11       Impact factor: 8.860

7.  Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.

Authors:  J van den Born; A A van Kraats; M A Bakker; K J Assmann; L P van den Heuvel; J H Veerkamp; J H Berden
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

8.  ECM gene expression and its modulation by insulin in diabetic rats.

Authors:  M Fukui; T Nakamura; I Ebihara; I Shirato; Y Tomino; H Koide
Journal:  Diabetes       Date:  1992-12       Impact factor: 9.461

9.  Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy.

Authors:  H Makino; S Ikeda; T Haramoto; Z Ota
Journal:  Nephron       Date:  1992       Impact factor: 2.847

10.  Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulfate proteoglycan and laminin.

Authors:  H Shimomura; R G Spiro
Journal:  Diabetes       Date:  1987-03       Impact factor: 9.461

View more
  13 in total

1.  Adipose stem cells' antagonism in glycosylation of D-galactose-induced skin aging of nude mice and its skin recovery function.

Authors:  Haiying Wang; Shuyue Wei; Xinxin Xue; Yuntian You; Qiang Ma
Journal:  Int J Immunopathol Pharmacol       Date:  2016-02-25       Impact factor: 3.219

2.  Effect of hyperglycemic condition on proteoglycan secretion in cultured human endothelial cells.

Authors:  Sedegheh Gharagozlian; Jørgen Borrebaek; Tore Henriksen; Tone Kristin Omsland; Hamid Shegarfi; Svein Olav Kolset
Journal:  Eur J Nutr       Date:  2006-06-29       Impact factor: 5.614

3.  A comparative proteomic study of nephrogenesis in intrauterine growth restriction.

Authors:  Qian Shen; Hong Xu; Li-Ming Wei; Jing Chen; Hai-Mei Liu; Wei Guo
Journal:  Pediatr Nephrol       Date:  2010-02-04       Impact factor: 3.714

4.  Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes.

Authors:  Ahmed A Mostafa; Edward W Randell; Sudesh C Vasdev; Vicki D Gill; Yingchun Han; Vereesh Gadag; Ahmed A Raouf; Hala El Said
Journal:  Mol Cell Biochem       Date:  2007-02-21       Impact factor: 3.396

5.  High-glucose and advanced glycosylation end products increased podocyte permeability via PI3-K/Akt signaling.

Authors:  Tae-Sun Ha
Journal:  J Mol Med (Berl)       Date:  2010-01-08       Impact factor: 4.599

6.  Effects of concentrated growth factor and nanofat on aging skin of nude mice induced by D-galactose.

Authors:  W Sun; T Li; H Yao; L Kang; F Dong
Journal:  Physiol Res       Date:  2021-05-12       Impact factor: 1.881

7.  Ginseng total saponin improves podocyte hyperpermeability induced by high glucose and advanced glycosylation endproducts.

Authors:  Tae-Sun Ha; Ji-Young Choi; Hye-Young Park; Jin-Seok Lee
Journal:  J Korean Med Sci       Date:  2011-10-01       Impact factor: 2.153

8.  Effects of interleukin-13 and montelukast on the expression of zonula occludens-1 in human podocytes.

Authors:  Se Jin Park; Moin A Saleem; Ja-Ae Nam; Tae-Sun Ha; Jae Il Shin
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

9.  Regulation of type IV collagen alpha chains of glomerular epithelial cells in diabetic conditions.

Authors:  Tae-Sun Ha; Eun-Jeong Hong; Eun-Mi Ahn; Hee-Yul Ahn
Journal:  J Korean Med Sci       Date:  2009-09-24       Impact factor: 2.153

10.  Ginseng total saponin modulates podocyte p130Cas in diabetic condition.

Authors:  Tae-Sun Ha; Jin-Seok Lee; Ji-Young Choi; Hye-Young Park
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.